Global Generic Drugs Market Will Grow Steadily At A CAGR Of 10.53% During The Period 2016-2020


Posted October 17, 2016 by ShrikantM

Researchmoz added Most up-to-date research on "Global Generic Drugs Market 2016-2020" to its huge collection of research reports.

 
Generic drugs have the same chemical formula, dosage form, potency, route of administration, quality, and intended use as that of patented branded drugs. They cost 80%-85% lesser than their branded counterparts and are available soon after the patent expiries of original drugs. However, they are similar to original drugs in terms of safety, quality, and effectiveness. Manufacturers need to apply for an Abbreviated New Drug Application (ANDA) approval to receive approval of generics.

Technavios analysts forecast the global generic drugs market to grow at a CAGR of 10.53% during the period 2016-2020.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=729247

Covered in this report
The report covers the present scenario and the growth prospects of the global generic drugs market for 2016-2020. To calculate the market size, it considers revenue generated from the sales of simple generics, super generics, and biosimilars.

The market is divided into the following segments based on geography:

Americas
APAC
EMEA

Recent report, Global Generic Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Teva Pharmaceuticals
Sandoz
Allergan
Mylan
Sun Pharmaceuticals
STADA Arzneimittel

Other prominent vendors

Abbott
Amgen
Apotex
Aspen
AstraZeneca
Aurobindo Pharma
Baxter
Berlin-Chemie
Biocon
Biogen
Boehringer Ingelheim
Celltrion
Cipla
Coherus Biosciences
Dr. Reddy's Laboratory
Daiichi Sankyo
Eli Lilly
Emcure Pharmaceuticals
Eurofarma Laboratories
Gedeon Richter
Gilead Sciences
GlaxoSmithKline
Hospira
Impax
InnoPharma
Intas Pharmaceuticals
Jannsen
Lupin
Merck
Mitsubishi Tanabe Pharma
Momenta Pharmaceuticals
Natco Pharma
Nexus Pharmaceuticals
Novo Nordisk
Orchid Chemicals & Pharmaceuticals
Parenteral Drugs India
Par Pharmaceutical
Pfizer
Piramal (Abbott Laboratories)
Roche Holdings
Sanofi
Synthon
Towa
Valeant Pharmaceuticals
Zentiva
Zhejiang Chira Medicine Chemicals
Zhejiang Hisun Pharmaceutical
Zydus Cadila Healthcare

Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease

Market driver

Patent expiry of top-selling drugs
For a full, detailed list, view our report

Market challenge

Threat of counterfeit drugs
For a full, detailed list, view our report

Market trend

Outsourcing of drug development activities
For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=729247
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Researchmoz Global Pvt. Ltd.
Country United States
Categories Business , Marketing
Tags cardiovascular devices , generic drugs market , market research reports
Last Updated October 17, 2016